BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 3259672)

  • 1. Enhancement of the binding of C1q to immune complexes by polyethylene glycol.
    Wines BD; Easterbrook-Smith SB
    Mol Immunol; 1988 Mar; 25(3):263-6. PubMed ID: 3259672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative analysis of the interaction between immune complex and C1q complement subcomponent. The role of interdomain interactions in rabbit IgG in binding of C1q to immune precipitates.
    Vonderviszt F; Török J; Lakatos S; Kilár F; Závodszky P
    Biochem J; 1987 Apr; 243(2):449-55. PubMed ID: 3498482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyethylene glycol enhances the binding of C1q to circulating immune complexes.
    Hack CE; Eerenberg-Belmer AJ; Hannema AJ; Out TA; Aalberse RC
    J Immunol Methods; 1981; 44(2):211-21. PubMed ID: 6792284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the first component of complement, C1, by a monoclonal antibody recognizing the C chain of C1q.
    Heinz HP; Burger R; Golan MD; Loos M
    J Immunol; 1984 Feb; 132(2):804-8. PubMed ID: 6606678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-C1q column: ligand specific purification of immune complexes from human serum or plasma. Analysis of the interaction between C1q and immune complexes.
    Kilgallon W; Amlot PL; Williams BD
    Clin Exp Immunol; 1982 Jun; 48(3):705-14. PubMed ID: 6811171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of immune complexes in the activation of the first component of human complement.
    Ziccardi RJ
    J Immunol; 1984 Jan; 132(1):283-8. PubMed ID: 6317744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The binding and activation of the Clr-Cls subunit of the first component of human complement.
    Hughes-Jones NC; Gorick BD
    Mol Immunol; 1982 Sep; 19(9):1105-12. PubMed ID: 6292705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-IgG type test to assay circulating immune complexes from polyethylene glycol precipitates compared with C1q binding and Raji cell tests.
    Levinson SS; Goldman J
    Clin Biochem; 1984 Dec; 17(6):341-4. PubMed ID: 6335066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The binding site for C1q on IgG.
    Duncan AR; Winter G
    Nature; 1988 Apr; 332(6166):738-40. PubMed ID: 3258649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the first component of human complement, C1, by monoclonal antibodies directed against different domains of subcomponent C1q.
    Kilchherr E; Schumaker VN; Phillips ML; Curtiss LK
    J Immunol; 1986 Jul; 137(1):255-62. PubMed ID: 3486914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of immune precipitation by purified classical pathway complement components.
    Naama JK; Hamilton AO; Yeung-Laiwah AC; Whaley K
    Clin Exp Immunol; 1984 Nov; 58(2):486-92. PubMed ID: 6333948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of C1q subcomponent with immunoglobulin M.
    Kimak E; Tomaszewski JJ
    Acta Biochim Pol; 1986; 33(3):179-85. PubMed ID: 2433858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of circulating immune complexes by chicken anti-human C3 and anti-human C1q microELISA.
    Larsson A; Jonsson L; Sjöquist J
    J Immunol Methods; 1988 Oct; 113(1):93-9. PubMed ID: 3262687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody to a cryptic, solid phase C1Q antigen in membranoproliferative nephritis.
    Strife CF; Leahy AE; West CD
    Kidney Int; 1989 Mar; 35(3):836-42. PubMed ID: 2785226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Interaction between fibronectin and aggregated IgG].
    Menzel EJ; Borth W; Kaik B
    Wien Klin Wochenschr; 1983 Dec; 95(24):880-4. PubMed ID: 6608184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification and characterization of the 1q subcomponent of canine complement and its use in the 125I-C1q binding assay for detection of immune complexes.
    Wu CC; Bey RF; Loken KI
    Am J Vet Res; 1988 Jun; 49(6):865-9. PubMed ID: 3135770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for the presence of autoantibodies to the collagen-like portion of C1q in systemic lupus erythematosus.
    Antes U; Heinz HP; Loos M
    Arthritis Rheum; 1988 Apr; 31(4):457-64. PubMed ID: 3258749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The presence of histidine residues at or near the C1q binding site of rabbit immunoglobulin G.
    McCall MN; Easterbrook-Smith SB
    Biochim Biophys Acta; 1987 Mar; 912(1):9-15. PubMed ID: 3493808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of C1q-bearing immune complexes by a monoclonal anti-C1q ELISA system.
    Antes U; Heinz HP; Loos M
    J Immunol Methods; 1987 Sep; 102(2):149-56. PubMed ID: 2443573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The complement subcomponent C1q mediates binding of immune complexes and aggregates to endothelial cells in vitro.
    Daha MR; Miltenburg AM; Hiemstra PS; Klar-Mohamad N; Van Es LA; Van Hinsbergh VW
    Eur J Immunol; 1988 May; 18(5):783-7. PubMed ID: 3259929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.